Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy
Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.
1 other identifier
interventional
23
1 country
1
Brief Summary
This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2013
CompletedStudy Start
First participant enrolled
July 1, 2013
CompletedFirst Posted
Study publicly available on registry
July 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2019
CompletedResults Posted
Study results publicly available
July 19, 2022
CompletedAugust 16, 2022
August 1, 2022
5.6 years
June 28, 2013
May 27, 2022
August 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Opioid Consumption (Mean Number of 5mg Oxycontin Tablets Consumed)
Consumption of 5mg Oxycontin tablets will be assessed on Post Operative Days 1, 2 \& 3.
Post Operative Day 1, 2 & 3
Secondary Outcomes (1)
Pain Scores
Post Operative Day 1, 2 & 3
Other Outcomes (2)
Number of Patients Reporting Sleep Disturbance
Post Operative Day 1, 2 & 3
Satisfaction With Pain Management
Post Operative Day 1, 2 & 3
Study Arms (2)
Liposomal bupivacaine
EXPERIMENTALUltrasound guided injection of liposomal bupivacaine for patients undergoing hip arthroscopy
Bupivacaine
ACTIVE COMPARATORBupivacaine (around the anterior, lateral and medial aspect of hip joint) for patients undergoing hip arthroscopy
Interventions
(Ultrasound guided injection of liposomal bupivacaine) for patients undergoing hip arthroscopy
(around the anterior, lateral and medial aspect of hip joint) for patients undergoing hip arthroscopy
Eligibility Criteria
You may qualify if:
- Patients having hip arthroscopy
You may not qualify if:
- History of neurologic disease, neuropathy, diabetes
- Allergy to local anesthetic solution
- Chronic use of narcotics
- Inability to give consent/cooperate with study
- History of previous hip arthroscopy on the ipsilateral side
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saint Francis Hospital and Medical Center
Hartford, Connecticut, 06105, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Study was terminated early leading to limited number of study subjects.
Results Point of Contact
- Title
- Sanjay Sinha, MD
- Organization
- Saint Francis Hospital and Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Sanjay Sinha, MD
Saint Francis Hospital and Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2013
First Posted
July 24, 2013
Study Start
July 1, 2013
Primary Completion
January 30, 2019
Study Completion
January 30, 2019
Last Updated
August 16, 2022
Results First Posted
July 19, 2022
Record last verified: 2022-08